Global Scleroderma Initiative
Scleroderma Research Foundation
Scleroderma Foundation
Federation of European Scleroderma Associations (FESCA)
Saturday, December 26, 2015
Wednesday, December 23, 2015
FDA approves new orphan drug...
12/23/2015 03:42:00 AM
No comments
FDA approves new orphan drug to treat pulmonary arterial hypertension.
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
Click here for more
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
Click here for more
Thursday, December 3, 2015
Intracellular calcium integrates complex signaling to control stem cell activity...
12/03/2015 02:16:00 AM
No comments
Subscribe to:
Posts (Atom)